# Aquinox Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aquinox-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Vancouver, Canada
- Website: www.aqxpharma.com
- Total disclosed funding: $58M
- Latest round: Series C (Apr 3, 2013)
- Investors on record: 7

## About

Founded in 2006 and based in Vancouver, Canada, Aquinox Pharmaceuticals, Inc. operates as a pharmaceutical company that focuses on treating inflammation and blood cancer.

## Funding rounds

- Series C, Apr 3, 2013, $18M — Ventures West Capital, Johnson & Johnson Innovation, Baker Brothers Advisors, Pfizer Venture Investments, Augment Investments Ltd., Pharmstandard International S.A.
- Series B, Jun 17, 2010, $25M — Ventures West Capital, Johnson & Johnson Innovation, BC Advantage Funds, Baker Brothers Advisors, Pfizer Venture Investments
- Series A, Jun 13, 2007, $15M — Ventures West Capital, Johnson & Johnson Innovation, BC Advantage Funds, Baker Brothers Advisors

## Investors

- Ventures West Capital (https://capitalatlas.ai/funds/ventures-west-capital) — Series A, Series B, Series C
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series A, Series B, Series C
- BC Advantage Funds (https://capitalatlas.ai/funds/bc-advantage-funds) — Series A, Series B
- Baker Brothers Advisors (https://capitalatlas.ai/funds/baker-brothers-advisors) — Series A, Series B, Series C
- Pfizer Venture Investments (https://capitalatlas.ai/funds/pfizer-venture-investments) — Series B, Series C
- Augment Investments Ltd. — Series C
- Pharmstandard International S.A. — Series C